Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Herpes simplex Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 47 articles: HTML format

Single Articles

June 2025
1. SHIO S, Kato A, Kawasaki J, Takeshima K, et al
   Impact of the changes in substrate specificity of herpes simplex virus 1 protein kinase Us3 on viral infection in vitro and in vivo.
   J Virol. 2025 Jun 30:e0040025. doi: 10.1128/jvi.00400.
   PubMed     Abstract available
   
   
   
2. WANG S, Jaggi U, Oh JJ, Ghiasi H, et al
   IFNbeta absence compensates for LAT functions in latency reactivation and T cell exhaustion.
   J Virol. 2025;99:e0037425.
   PubMed     Abstract available
   
   
   April 2025
3. JONES C
   Human alpha-herpesvirus 1 (HSV-1) viral replication and reactivation from latency are expedited by the glucocorticoid receptor.
   J Virol. 2025;99:e0030325.
   PubMed     Abstract available
   
   
   
4. HARRISON KS, Cowan SR, Jones C
   Murine nasal-associated lymphoid tissue (NALT) harbors human alphaherpesvirus 1 (HSV-1) DNA during latency, and dexamethasone triggers viral replication.
   J Virol. 2025;99:e0225124.
   PubMed     Abstract available
   
   
   
5. WEISS E, Whisnant AW, Hennig T, Djakovic L, et al
   HSV-1 infection induces a downstream shift of the +1 nucleosome.
   J Virol. 2025;99:e0208624.
   PubMed     Abstract available
   
   
   
6. QIU L, Gao X, Shao X, Xi J, et al
   HSV-1 UL56 protein recruits cellular NEDD4-family ubiquitin ligases to suppress CD1d expression and NKT cell function.
   J Virol. 2025;99:e0214024.
   PubMed     Abstract available
   
   
   
7. CHENTOUFI AA, Prakash S, Vahed H, Karan S, et al
   A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits.
   J Virol. 2025 Apr 10:e0013525. doi: 10.1128/jvi.00135.
   PubMed     Abstract available
   
   
   March 2025
8. HULL MA, Pritchard SM, Nicola AV
   Herpes simplex virus 1 envelope glycoprotein C shields glycoprotein D to protect virions from entry-blocking antibodies.
   J Virol. 2025 Mar 26:e0009025. doi: 10.1128/jvi.00090.
   PubMed     Abstract available
   
   
   
9. KALAMVOKI M
   HSV-1 virions and related particles: biogenesis and implications in the infection.
   J Virol. 2025;99:e0107624.
   PubMed     Abstract available
   
   
   February 2025
10. RICHARDO T, Liu X, Dohner K, Chao T-Y, et al
    Herpes simplex virus assembly and spread in murine skin after infection from the outside.
    J Virol. 2025 Feb 13:e0163824. doi: 10.1128/jvi.01638.
    PubMed     Abstract available
    
    
    November 2024
11. NIEMEYER CS, Merle L, Bubak AN, Baxter BD, et al
    Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity.
    J Virol. 2024;98:e0096824.
    PubMed     Abstract available
    
    
    
12. MULLON PJ, Maldonado-Luevano E, Mehta KPM, Mohni KN, et al
    The herpes simplex virus alkaline nuclease is required to maintain replication fork progression.
    J Virol. 2024 Nov 7:e0183624. doi: 10.1128/jvi.01836.
    PubMed     Abstract available
    
    
    October 2024
13. SINGH N, Zachariah S, Phillips AT, Tscharke D, et al
    Lytic promoter activity during herpes simplex virus latency is dependent on genome location.
    J Virol. 2024 Oct 21:e0125824. doi: 10.1128/jvi.01258.
    PubMed     Abstract available
    
    
    September 2024
14. WHISNANT AW, Dyck Dionisi O, Salazar Sanchez V, Rappold JM, et al
    Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7.
    J Virol. 2024 Sep 24:e0117824. doi: 10.1128/jvi.01178.
    PubMed     Abstract available
    
    
    August 2024
15. FINNEN RL, Muradov JH, Le Sage V, Banfield BW, et al
    Disruption of herpes simplex virus type 2 pUL21 phosphorylation impairs secondary envelopment of cytoplasmic nucleocapsids.
    J Virol. 2024 Aug 13:e0065624. doi: 10.1128/jvi.00656.
    PubMed     Abstract available
    
    
    
16. BERGEMAN MH, Velarde K, Hargis HL, Glenn HL, et al
    The Rab6 post-Golgi secretory pathway contributes to herpes simplex virus 1 (HSV-1) egress.
    J Virol. 2024 Aug 13:e0059924. doi: 10.1128/jvi.00599.
    PubMed     Abstract available
    
    
    July 2024
17. LIU S, Maruzuru Y, Takeshima K, Koyanagi N, et al
    Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis.
    J Virol. 2024 Jul 17:e0073724. doi: 10.1128/jvi.00737.
    PubMed     Abstract available
    
    
    June 2024
18. WHITE S, Roller R
    Herpes simplex virus type-1 cVAC formation in neuronal cells is mediated by dynein motor function and glycoprotein retrieval from the plasma membrane.
    J Virol. 2024 Jun 20:e0071324. doi: 10.1128/jvi.00713.
    PubMed     Abstract available
    
    
    
19. HSU Z-S, Engel EA, Enquist LW, Koyuncu OO, et al
    Neuronal expression of herpes simplex virus-1 VP16 protein induces pseudorabies virus escape from silencing and reactivation.
    J Virol. 2024 Jun 13:e0056124. doi: 10.1128/jvi.00561.
    PubMed     Abstract available
    
    
    
20. WANG S, Song X, Rajewski A, Santiskulvong C, et al
    Ample evidence for the presence of HSV-1 LAT in non-neuronal ganglionic cells of mice and humans.
    J Virol. 2024;98:e0044124.
    PubMed    
    
    
    
21. OUWENDIJK WJD, Roychoudhury P, Cunningham AL, Jerome KR, et al
    Reply to Wang et al., "Ample evidence for the presence of HSV-1 LAT in non-neuronal ganglionic cells of mice and humans".
    J Virol. 2024;98:e0052024.
    PubMed    
    
    
    May 2024
22. KATO A, Iwasaki R, Takeshima K, Maruzuru Y, et al
    Identification of a novel neurovirulence factor encoded by the cryptic orphan gene UL31.6 of herpes simplex virus 1.
    J Virol. 2024 May 31:e0074724. doi: 10.1128/jvi.00747.
    PubMed     Abstract available
    
    
    
23. BIRKENHEUER CH, Baines JD
    Aberrant RNA polymerase initiation and processivity on the genome of a herpes simplex virus 1 mutant lacking ICP27.
    J Virol. 2024 May 23:e0071224. doi: 10.1128/jvi.00712.
    PubMed     Abstract available
    
    
    April 2024
24. DOMANICO LF, Dunn GP, Kobiler O, Taylor MP, et al
    A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection.
    J Virol. 2024 Apr 23:e0003224. doi: 10.1128/jvi.00032.
    PubMed     Abstract available
    
    
    
25. QUADIRI A, Prakash S, Dhanushkodi NR, Singer M, et al
    Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4(+) and CD8(+) T cells and protects against recurrent
    J Virol. 2024 Apr 8:e0159623. doi: 10.1128/jvi.01596.
    PubMed     Abstract available
    
    
    March 2024
26. JAGGI U, Matundan HH, Oh JJ, Ghiasi H, et al
    Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels.
    J Virol. 2024;98:e0201023.
    PubMed     Abstract available
    
    
    
27. OUWENDIJK WJD, Roychoudhury P, Cunningham AL, Jerome KR, et al
    Reanalysis of single-cell RNA sequencing data does not support herpes simplex virus 1 latency in non-neuronal ganglionic cells in mice.
    J Virol. 2024 Mar 6:e0185823. doi: 10.1128/jvi.01858.
    PubMed     Abstract available
    
    
    February 2024
28. DOCHNAL SA, Whitford AL, Francois AK, Krakowiak PA, et al
    c-Jun signaling during initial HSV-1 infection modulates latency to enhance later reactivation in addition to directly promoting the progression to full reactivation.
    J Virol. 2024;98:e0176423.
    PubMed     Abstract available
    
    
    January 2024
29. BERGEMAN MH, Hernandez MQ, Diefenderfer J, Drewes JA, et al
    Individual herpes simplex virus 1 (HSV-1) particles exit by exocytosis and accumulate at preferential egress sites.
    J Virol. 2024 Jan 9:e0178523. doi: 10.1128/jvi.01785.
    PubMed     Abstract available
    
    
    December 2023
30. GRAMS TR, Edwards TG, Bloom DC
    A viral lncRNA tethers HSV-1 genomes at the nuclear periphery to establish viral latency.
    J Virol. 2023;97:e0143823.
    PubMed     Abstract available
    
    
    November 2023
31. VELUSAMY T, Singh N, Croft S, Smith S, et al
    The expression and function of HSV ICP47 and its promoter in mice.
    J Virol. 2023;97:e0110723.
    PubMed     Abstract available
    
    
    October 2023
32. WAISNER H, Lasnier S, Suma SM, Kalamvoki M, et al
    Effects on exocytosis by two HSV-1 mutants unable to block autophagy.
    J Virol. 2023;97:e0075723.
    PubMed     Abstract available
    
    
    
33. ZUBKOVIC A, Gomes C, Parchure A, Cesarec M, et al
    HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia.
    J Virol. 2023;97:e0073023.
    PubMed     Abstract available
    
    
    
34. YOU H, Lin Y, Lin F, Yang M, et al
    Correction for You et al., "beta-Catenin Is Required for the cGAS/STING Signaling Pathway but Antagonized by the Herpes Simplex Virus 1 US3 Protein".
    J Virol. 2023 Oct 16:e0098423. doi: 10.1128/jvi.00984.
    PubMed    
    
    
    
35. YUAN H, You J, You H, Zheng C, et al
    Correction for Yuan et al., "Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity".
    J Virol. 2023 Oct 16:e0098323. doi: 10.1128/jvi.00983.
    PubMed    
    
    
    
36. HUANG J, You H, Su C, Li Y, et al
    Correction for Huang et al., "Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity".
    J Virol. 2023 Oct 16:e0098223. doi: 10.1128/jvi.00982.
    PubMed    
    
    
    
37. ZHENG C
    Correction for Zheng, "Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1".
    J Virol. 2023 Oct 16:e0098123. doi: 10.1128/jvi.00981.
    PubMed    
    
    
    
38. HARRISON KS, Wijesekera N, Robinson AGJ, Santos VC, et al
    Impaired glucocorticoid receptor function attenuates herpes simplex virus 1 production during explant-induced reactivation from latency in female mice.
    J Virol. 2023 Oct 12:e0130523. doi: 10.1128/jvi.01305.
    PubMed     Abstract available
    
    
    September 2023
39. BOURNE N, Keith CA, Miller AL, Pyles RB, et al
    Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    J Virol. 2023;97:e0066923.
    PubMed     Abstract available
    
    
    
40. DUNN LEM, Baines JD
    Herpes simplex virus 1 immediate early transcription initiation, pause-release, elongation, and termination in the presence and absence of ICP4.
    J Virol. 2023 Sep 27:e0096023. doi: 10.1128/jvi.00960.
    PubMed     Abstract available
    
    
    June 2023
41. SANDERS LS 3RD, Comar CE, Srinivas KP, Lalli J, et al
    Herpes Simplex Virus-1 ICP27 Nuclear Export Signal Mutants Exhibit Cell Type-Dependent Deficits in Replication and ICP4 Expression.
    J Virol. 2023 Jun 13:e0195722. doi: 10.1128/jvi.01957.
    PubMed     Abstract available
    
    
    
42. DE LA CRUZ NC, Mockel M, Niehues H, Rubsam M, et al
    Ex Vivo Infection of Human Skin Models with Herpes Simplex Virus 1: Accessibility of the Receptor Nectin-1 during Formation or Impairment of Epidermal Barriers Is Restricted by Tight Junctions.
    J Virol. 2023 Jun 8:e0026223. doi: 10.1128/jvi.00262.
    PubMed     Abstract available
    
    
    May 2023
43. WEISS E, Hennig T, Grassl P, Djakovic L, et al
    HSV-1 Infection Induces a Downstream Shift of Promoter-Proximal Pausing for Host Genes.
    J Virol. 2023;97:e0038123.
    PubMed     Abstract available
    
    
    April 2023
44. CUDDY SR, Cliffe AR
    The Intersection of Innate Immune Pathways with the Latent Herpes Simplex Virus Genome.
    J Virol. 2023 Apr 27:e0135222. doi: 10.1128/jvi.01352.
    PubMed     Abstract available
    
    
    
45. SANTOS VC, Ostler JB, Harrison KS, Jones C, et al
    Slug, a Stress-Induced Transcription Factor, Stimulates Herpes Simplex Virus 1 Replication and Transactivates a cis-Regulatory Module within the VP16 Promoter.
    J Virol. 2023 Apr 6:e0007323. doi: 10.1128/jvi.00073.
    PubMed     Abstract available
    
    
    February 2023
46. WANG J, Qin X, Huang Y, Zhang G, et al
    Sirt1 Negatively Regulates Cellular Antiviral Responses by Preventing the Cytoplasmic Translocation of Interferon-Inducible Protein 16 in Human Cells.
    J Virol. 2023;97:e0197522.
    PubMed     Abstract available
    
    
    
47. GRAMS TR, Edwards TG, Bloom DC
    HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons.
    J Virol. 2023;97:e0193522.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge.